Fluids in acute respiratory distress syndrome: Pros and cons

Current Opinion in Critical Care

Volumn 20, Issue 1, 2014, Pages 104-112

  Silva, Pedro L ^a   Pelosi, Paolo ^b   Rocco, Patricia R M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

acute kidney injury; acute respiratory distress syndrome; colloids; resuscitation; sepsis

Indexed keywords

ADULT; ALBUMINS; CRITICAL ILLNESS; ENDOTHELIAL CELLS; EVIDENCE-BASED MEDICINE; FEMALE; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; MALE; PRACTICE GUIDELINES AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS;

EID: 84895071826     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000049     Document Type: Review

References (50)

1. Leathes JB, Starling EH. On the absorption of salt solutions from the pleural cavities. J Physiol 1895; 18:106-116.
2. Adamson RH, Lenz JF, Zhang X, et al. Oncotic pressures opposing filtration across nonfenestrated rat microvessels. J Physiol 2004; 557: 889-907.
3. Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010; 87:198-210.
4. Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med 2012; 18:1217-1223.
5. Nieuwdorp M, van Haeften TW, Gouverneur MC, et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006; 55:480-486.
6. Herwig MC, Tsokos M, Hermanns MI, et al. Vascular endothelial cadherin expression in lung specimens of patients with sepsis-induced acute respiratory distress syndrome and endothelial cell cultures. Pathobiology 2013; 80:245-251.
7. London NR, Zhu W, Bozza FA, et al. Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2010; 2:23ra19.
8. Conway DE, Breckenridge MT, Hinde E, et al. Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1. Curr Biol 2013; 23:1024-1030.
9. Moriondo A, Marcozzi C, Bianchin F, et al. Impact of mechanical ventilation and fluid load on pulmonary glycosaminoglycans. Respir Physiol Neurobiol 2012; 181:308-320.
10. Mahler SA, Conrad SA, Wang H, et al. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med 2011; 29:670-674.
11. Feldheiser A, Pavlova V, Bonomo T, et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth 2013; 110:231-240.
12. Jamnicki M, Zollinger A, Seifert B, et al. The effect of potato starch derived and corn starch derived hydroxyethyl starch on in vitro blood coagulation. Anaesthesia 1998; 53:638-644.
13. Reggiori G, Occhipinti G, De Gasperi A, et al. Early alterations of red blood cell rheology in critically ill patients. Crit Care Med 2009; 37:3041- 3046.
14. Heckel K, Winkelmann B, Strunden MS, et al. Tetrastarch sustains pulmonary microvascular perfusion and gas exchange during systemic inflammation. Crit Care Med 2012; 40:518-531.
15. Dubin A, Pozo MO, Casabella CA, et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010; 25:659; e651-e658.
16. Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med 2010; 36:949-955.
17. Neff TA, Fischler L, Mark M, et al. The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 2005; 100:1773-1780.
18. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172-178.
19. Doi K, Yuen PS, Eisner C, et al. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009; 20:1217- 1221.
20. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288:1499-1507.
21. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911.
22. Crystalloid versus Hydroxyethyl Starch Trial (CHEST) management Committee. The Crystalloid versus Hydroxyethyl Starch Trial: protocol for a multicentre randomised controlled trial of fluid resuscitation with 6% hydroxyethyl starch (130/0.4) compared to 0.9% sodium chloride (saline) in intensive care patients on mortality. Intensive Care Med 2011; 37:816- 823.
23. Bayer O, Reinhart K, Sakr Y, et al. Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med 2011; 39:1335-1342.
24. Finfer S, McEvoy S, Bellomo R, et al. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011; 37:86-96.
25. Leung AD, Wong KH, Tien J. Plasma expanders stabilize human microvessels in microfluidic scaffolds. J Biomed Mater Res A 2012; 100:1815- 1822.
26. Lobo DN, Stanga Z, Aloysius MM, et al. Effect of volume loading with 1 l intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers. Crit Care Med 2010; 38:464-470.
27. Van der Linden PJ, De Hert SG, Deraedt D, et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesth Analg 2005; 101:629-634.
28. Martin C, Jacob M, Vicaut E, et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118:387-394.
29. James MF, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107:693-702.
30. Van Der Linden P, James M, Mythen M, et al. Safety of modern starches used during surgery. Anesth Analg 2013; 116:35-48.
31. Faraklas I, Lam U, Cochran A, et al. Colloid normalizes resuscitation ratio in pediatric burns. J Burn Care Res 2011; 32:91-97.
32. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124- 134.
33. Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012; 16:R94.
34. Haase N, Perner A, Hennings LI, et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-Analysis and trial sequential analysis. BMJ 2013; 346:f839.
35. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39:165-228.
36. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34:17-60.
37. Magder S. Protocols, physiology, and trials of hydroxyethyl starch. N Engl J Med 2012; 367:1265; author reply 1267.
38. Ogilvie MP, Pereira BM, McKenney MG, et al. First report on safety and efficacy of hetastarch solution for initial fluid resuscitation at a level 1 trauma center. J Am Coll Surg 2010; 210:870-880; 880-872.
39. Boussekey N, Darmon R, Langlois J, et al. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care 2010; 14:R40.
40. Wafaisade A, Wutzler S, Lefering R, et al. Drivers of acute coagulopathy after severe trauma: a multivariate analysis of 1987 patients. Emerg Med J 2010; 27:934-939.
41. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluidmanagement strategies in acute lung injury. N Engl J Med 2006; 354:2564- 2575.
42. Sakr Y, Vincent JL, Reinhart K, et al. High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest 2005; 128:3098-3108.
43. Martin GS, Mangialardi RJ, Wheeler AP, et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002; 30:2175-2182.
44. Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005; 33:1681-1687.
45. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693.
46. Sheu CC, Gong MN, Zhai R, et al. Clinical characteristics and outcomes of sepsis-related vs nonsepsis-related ARDS. Chest 2010; 138:559-567.
47. Silva PL, Guldner A, Uhlig C, et al. Effects of intravascular volume replacement on lung and kidney function and damage in nonseptic experimental lung injury. Anesthesiology 2013; 118:395-408.
48. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012; 122:2731-2740.
49. Bhattacharya J, Matthay MA. Regulation and repair of the alveolar-capillary barrier in acute lung injury. Annu Rev Physiol 2013; 75:593-615.
50. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013; 369:1243-1251.